广州佳途科技股份有限公司/CATO Research Chemicals Inc.(简称:CATO / 佳途科技)
Login | Register
Wish list (0)
Cart (0)
EN / ZH
  • Home
  • Products
  • Services
    • Quality Control Sample
    • Intermediates Synthesis
    • Preparation Separation & Structural Identification Services​​
  • Documents
  • News
  • About Us
  • Contact Us
Login | Register
Wish list (0)
Cart (0)
EN / ZH
Login | Register
Wish list (0)
Cart (0)
EN / ZH
  • Home
  • Products
  • Services
    • Quality Control Sample
    • Intermediates Synthesis
    • Preparation Separation & Structural Identification Services​​
  • Documents
  • News
  • About Us
  • Contact Us
Login | Register
Wish list (0)
Cart (0)
EN / ZH
Home>News>CATO News>
Search HistoryClear
Structure Search
AI 智能搜索

CATO News

FAQs
  • CATO Attend 75th PITTCON Conference and Exposition

    CATO Attend 75th PITTCON Conference and Exposition

    From February 24-28, 2024, the 2024 Pittcon Analytical Chemistry and Spectroscopy Applications Conference and Exhibition will be held at the San Diego Convention Center.

    CATO|CATO|2025-07-28 16:53:08
  • Now Available | CATO Acyclovir EP Impurity R – Empowering Antiviral Drug Quality Control

    Now Available | CATO Acyclovir EP Impurity R – Empowering Antiviral Drug Quality Control

    To support quality research and registration submissions, CATO's in-house developed Impurity R reference standard features high purity and high stability, complete with comprehensive Certificate of Analysis (COA), making it widely applicable for process optimization, method development, registration dossier preparation, and various other application requirements.

    CATO|CATO|2025-08-25 14:42:20
  • FDA Adds 12 High-Risk Nitrosamine Impurities, Spotlighting Meglumine-Related NDSRIs

    FDA Adds 12 High-Risk Nitrosamine Impurities, Spotlighting Meglumine-Related NDSRIs

    Recently, the U.S. FDA updated its Nitrosamine Impurities Acceptable Intake Limits database, adding 12 new high-risk nitrosamine impurities. Among them, meglumine-related nitrosamine drug substance-related impurities (NDSRIs) have emerged as a major pharmaceutical safety concern, involving more than ten commonly used drugs such as delafloxacin meglumine, iopamidol meglumine, and gadodiamide meglumine.

    CATO|CATO|2025-08-11 15:46:08
  • Join us at CPHI China 2025 !

    Join us at CPHI China 2025 !

    I am writing to invite to meet you in China CPHI on June 24-26, 2025, here is our Booth: # Hall E2G36. Please let me know your preferred meeting time, if you are there.

    CATO|CATO|2025-08-04 11:14:55
  • 1
  • 2
  • 1
  • 2
0
0
Your name
Email
CAS No.
Item No.
Comments
Company
  • About Us
  • Contact Us
  • News
  • Help Center
Service
  • Quality Control Sample
  • Intermediates Synthesis
  • Preparation Separation & Structural Identification Services​​
Support
  • Products
  • Documents

Commercial / Technical Support

+86-20-81960175

Order / Customer Service Email:

standards@cato-chem.com

ISO 17034

ISO 17034

ISO 9001

©  CATO Research Chemicals Inc. 粤ICP备18108372号